Public opposition would be unseemly, so insurers and hospitals work behind the scenes against price transparency.
In a last-minute filing, the attorney general elected not to defend the health care law. The legal arguments in Texas v. Azar hinge on severability and legislative intent.
Some heavy-hitting health care organizations think that the prior authorization process needs improvement, saying in a consensus statement that it “can be burdensome for all involved—health care providers, health plans, and patients. Yet, there is wide variation in medical practice and adherence to evidence-based treatment.”
It is often an on-again, off-again disease, distressing partly because it is so unpredictable. It may defy the conventional wisdom about adherence and early treatment. And escalating prices have undercut cost-effectiveness arguments for the drugs that can keep it in check. Multiple sclerosis is a managed care nightmare.
The “waste-free formulary” under development by the Pacific Business Group on Health sounds promising, but ultimately may not deliver the impact to self-insured employers its creators are promising. The approach glosses over a critical question: What constitutes “high-value”? The definition of value plays a central role in determining the care that patients ultimately receive.
For organizations with a good strategy to reduce care variation, a hospital efficiency improvement program can provide the jolt of incentive that generates real improvement.
The Office of Personnel Management’s 2018: Federal Workforce Priorities Report reiterates what other studies have shown: Workers spend too much time sitting and not enough time doing some sort of physical activity. The OPM wants government agencies to focus more on giving workers opportunities to be more active at work.
The check marks in this table show current health-reform bills cosponsored by 15 key senators.
For anyone who’s ever felt that five minutes after you’ve been on vacation it seems as though you’d never gone, you’re not alone.